ACTUAL THERAPEUTIC STRATEGIES FOR HEPATOCELLULAR-CARCINOMA .1.

被引:0
|
作者
WALLNER, I [1 ]
HARTMANN, H [1 ]
RAMADORI, G [1 ]
机构
[1] UNIV GOTTINGEN,MED KLIN & POLIKLIN,GASTROENTEROL & ENPOKRINOL ABT,ROBERT KOCH STR 40,D-37075 GOTTINGEN,GERMANY
关键词
HEPATOMA PATHOLOGY; HEPATOMA ETIOLOGY; HEPATOMA EPIDEMIOLOGY; HEPATOMA DIAGNOSIS; HEPATOMA SCREENING;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is the most frequent primary malignancy of the liver, most prevalent in Asia and Africa but also showing a rising incidence worldwide. Chronic hepatitis B and C virus infection is the most important risk factor for HCC. More than half of the patients suffer from underlying liver cirrhosis. The prognosis is determined by tumor stage and residual capacity of the liver, the median survival being 0,9 to 12,8 months for patients receiving no specific treatment. In the East, early detection has been improved by screening programs which seem to be less valuable in the Western world.
引用
收藏
页码:150 / &
相关论文
共 50 条
  • [1] ACTUAL THERAPEUTIC STRATEGIES FOR HEPATOCELLULAR-CARCINOMA .2.
    WALLNER, I
    HARTMANN, H
    RAMADORI, G
    [J]. LEBER MAGEN DARM, 1994, 24 (05) : 187 - &
  • [2] STRATEGIES IN PREVENTION OF HEPATOCELLULAR-CARCINOMA BY VACCINATION
    DEINHARDT, F
    JILG, W
    [J]. LIVER CELL CARCINOMA, 1989, 51 : 509 - 516
  • [3] STRATEGIES IN THE STUDY OF HEPATOCELLULAR-CARCINOMA WORLDWIDE
    CROCE, LS
    BERCICH, L
    SASSO, F
    MASUTTI, F
    MOLINO, R
    TIRIBELLI, C
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1993, : 37 - 39
  • [4] HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS - THERAPEUTIC POSSIBILITIES
    PORCHERON, J
    CADI, F
    TARDIEU, D
    BALIQUE, JG
    [J]. ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1992, 28 (03): : 131 - 139
  • [5] THERAPEUTIC ACTIVITY AND EFFICACY OF ETOPOSIDE IN HEPATOCELLULAR-CARCINOMA
    DOMINGO, EO
    LINGAO, AL
    LAO, JY
    RAYMUNDO, MAA
    [J]. PHILIPPINE JOURNAL OF INTERNAL MEDICINE, 1982, 20 (02): : 106 - 112
  • [6] EARLY DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA THERAPEUTIC IMPLICATIONS
    BRUIX, J
    [J]. MEDICINA CLINICA, 1993, 100 (06): : 228 - 234
  • [7] INVASIVE THERAPEUTIC PROCEDURES IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA
    TARAZOV, PG
    PROKHOROVSKY, KV
    PIRTSKHALAVA, TL
    [J]. KHIRURGIYA, 1991, (04): : 153 - 154
  • [8] HEPATOCELLULAR-CARCINOMA - SEARCH FOR STRATEGIES IN EARLY DIAGNOSIS
    FARINATI, F
    CHIARAMONTE, M
    RUGGE, M
    SALVAGNINI, M
    ZAGOLIN, M
    GUIDO, M
    NACCARATO, R
    [J]. PATHOPHYSIOLOGY OF THE LIVER, 1988, 786 : 217 - 226
  • [9] BIOLOGY OF HEPATOCELLULAR NEOPLASIA IN THE MOUSE .1. HISTOGENESIS OF SAFROLE-INDUCED HEPATOCELLULAR-CARCINOMA
    LIPSKY, MM
    HINTON, DE
    KLAUNIG, JE
    TRUMP, BF
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1981, 67 (02) : 365 - 376
  • [10] DISTRIBUTION OF LIPIODOL AND ITS THERAPEUTIC VALUE IN HEPATOCELLULAR-CARCINOMA
    ARNOLD, MM
    KREEL, L
    CHAN, MSY
    LI, AKC
    [J]. LABORATORY INVESTIGATION, 1991, 64 (01) : A91 - A91